Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03133637 · ClinicalTrials.gov registry record
Ceftriaxone and Jaundice in Neonates
A clinical trial, sponsored by University of Rochester.
- Completed
- Registry status
- 27
- Enrollment target
NCT03133637: Completed study, sponsored by University of Rochester.
NCT03133637 is a clinical trial that has completed, run by University of Rochester. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03133637 has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
Ceftriaxone is an antibiotic often used for the management of sepsis. Neonates commonly have jaundice during the first postnatal week. Ceftriaxone will be given as standard of care for sepsis and investigators will observe the effect on jaundice.
Interventions
- DRUG ceftriaxone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2016-03 |
| Est. Completion | 2019-08-31 |
What the finished NCT03133637 record still lists
NCT03133637 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 27 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which ceftriaxone is the first listed.
NCT03133637 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03133637 about?
NCT03133637 is a clinical study titled "Ceftriaxone and Jaundice in Neonates". Ceftriaxone is an antibiotic often used for the management of sepsis. Neonates commonly have jaundice during the first postnatal week. Ceftriaxone will be given as standard of care for sepsis and investigators will observe the effect on jaundice.
What is the current status of trial NCT03133637?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2016-03. Estimated completion is 2019-08-31.
What interventions are being tested in trial NCT03133637?
The interventions under investigation include: ceftriaxone (DRUG).
Who is sponsoring clinical trial NCT03133637?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia